Sign in

CIK 0001937993 · <br>Emerging growth company

Cadrenal Therapeutics, Inc.

Sign in to watch
Ticker
CVKD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
880860746
Phone
904-300-0701
Business address
822 A1A NORTH, SUITE 306, PONTE VEDRA, FL, 32082
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Planned sale Chairman and CEO sold 7,400 shares at $3.03 ($22,422)
  7. 4 Planned sale Chairman, CEO and Interim CFO sold 11,156 shares at an average $3.04 ($33,919)
  8. 4 Planned sale Chairman, CEO and Interim CFO sold 11,444 shares at an average $3.48 ($39,829)
  9. 4 Planned sale Chairman, CEO and Interim CFO sold 4,126 shares at an average $3.18 ($13,110)
  10. 4 Open-market sale Chairman, CEO and Interim CFO sold 18,124 shares at an average $3.88 ($70,352)
  11. 4 Planned sale Chairman, CEO and Interim CFO sold 22,385 shares at an average $4.17 ($93,294)
  12. 4 Planned sale CEO and Chairman sold 8,285 shares at an average $4.37 ($36,209)
  13. 4 Planned sale CEO and Chairman sold 652 shares at an average $4.72 ($3,075)
  14. 4 Planned sale CEO and Chairman sold 12,763 shares at an average $5.44 ($69,451)
  15. 4 Planned sale CEO and Chairman sold 1,165 shares at $5.69 ($6,629)
  16. 4 Planned sale Chief Financial Officer sold 9,933 shares at $6.97 ($69,233)
  17. 4 Derivatives Options or other derivatives
  18. 3 Insider Initial Statement of Ownership
  19. 4 Planned sale Chief Financial Officer sold 3,600 shares at $13.99 ($50,364)
  20. 4 Planned sale CEO and Chairman sold 2,444 shares at an average $14.01 ($34,237)

Page 1 of 4 · 69 filings